Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Citra Borneo Utama Tbk (CBUT) Fair Value & Analysis

Consumer Defensive · ID · Market cap 1.6T IDR

Price700.00 IDR
Fair Value1,043 IDR
Upside+49.0%
Quality95/100
Evidence: High Range 556.35 IDR – 1,530 IDR

Fair value as of: Jun 24, 2026

Analysis

PT Citra Borneo Utama Tbk (CBUT) currently trades at 700.00 IDR, while our model-based Fair Value estimate is 1,043 IDR — implying the stock looks roughly 49.0% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

PT Citra Borneo Utama Tbk engages in palm oil refining, and trading activities in Indonesia and internationally. The company offers product and services, such as refined bleached deodorized palm oil, refined bleached deodorized palm olein, refined bleached deodorized palm stearin, palm fatty acid distillate, crude palm kernel oil, and palm kernel expeller. The company was founded in 2013 and is headquartered in Pangkalan Bun, Indonesia. PT Citra Borneo Utama Tbk operates as a subsidiary of PT Citra Borneo Indah.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is PT Citra Borneo Utama Tbk (CBUT) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1,043 IDR versus a price of 700.00 IDR — about +49% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CBUT?
Our 21-model fair value for PT Citra Borneo Utama Tbk is 1,043 IDR (as of Jun 24, 2026), built from audited fundamentals. The current price is 700.00 IDR.
What is the quality score of CBUT?
PT Citra Borneo Utama Tbk has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.